Polymorphisms in the gene for the ␣5 nicotinic acetylcholine receptor (nAChR) subunit are associated with vulnerability to nicotine addiction. However, the underlying normal functions of ␣5-containing nAChRs in the brain are poorly understood. Striatal dopamine (DA) transmission is critical to the acquisition and maintenance of drug addiction and is modulated strongly by nicotine acting at heteromeric ␤2-containing (␤2*) nAChRs. We explored whether ␣5 subunits, as well as ␣4, ␣6, and ␤3 subunits, participate in the powerful regulation of DA release probability by ␤2* nAChRs in nucleus accumbens (NAc) core and in dorsal striatum [caudatoputamen (CPu)]. We detected evoked dopamine release using fast-scan cyclic voltammetry at carbon-fiber microelectrodes in striatal slices from mice with deletions of ␣4, ␣5, ␣6, or ␤3 subunits. We show that the nAChR subtypes that dominantly regulate dopamine transmission depend critically upon ␣5 subunits in the dorsal CPu in ␣4␣5(non-␣6)␤2-nAChRs but not in NAc core, where ␣4␣6␤2␤3-nAChRs are required. These data reveal the distinct populations of nAChRs that govern DA transmission in NAc core versus dorsal CPu. Furthermore, they indicate that ␣5 subunits are critical to the regulation of DA transmission by ␣4␤2* nAChRs in regions of striatum associated with habitual and instrumental responses (dorsal CPu) rather than pavlovian associations (NAc).
Introduction
There has been longstanding interest in the nicotinic acetylcholine receptor (nAChR) subtypes that participate in nicotine addiction. Receptors containing ␣4 and ␤2 subunits are well known to be involved in nicotine's cellular and reinforcing effects. For example, deletion of either ␣4 or ␤2 subunits prevents nicotineinduced changes in DA neuron excitability and nicotine selfadministration in rodents (Picciotto et al., 1998; Maskos et al., 2005; Pons et al., 2008) . Recently, genome-wide association studies have identified that polymorphisms in nAChR genes in gene clusters for other subunits, ␣5/␣3/␤4 and ␣6/␤3, are associated with tobacco addiction (Thorgeirsson et al., 2008; Saccone et al., 2009; Bierut, 2010) . Allelic variation and expression levels of ␣5 subunits have been particularly strongly associated, across independent studies Wang et al., 2009; Bierut, 2010) . The ␣5 subunits, like ␤3 subunits, are accessory subunits that are known to modify the properties of ␣4-or ␣6-containing nAChRs respectively (Tumkosit et al., 2006; Grady et al., 2010; Kuryatov et al., 2011) , but the roles of ␣5-containing (␣5*) or ␤3* nAChRs in normal brain function and in nicotine action in situ are poorly understood.
Recently, ␣5* nAChRs in the habenulo-interpeduncular pathway have been shown to regulate nicotine intake (Fowler et al., 2011; Frahm et al., 2011) . However, nicotine dependence also critically involves striatal dopamine (DA). Mesostriatal DA neurons express a diverse array of subunits (␣3-7, ␤2-4), and it has been suggested that up to six possible types of ␤2* nAChRs are available in striatal DA axons for striatal ACh and nicotine to modulate DA transmission, namely, ␣4␤2, ␣4␣5␤2, ␣4␣6␤2␤3, ␣4␣6␤2, ␣6␤2␤3, and ␣6␤2 (Picciotto et al., 1998; Champtiaux et al., 2003; Gotti et al., 2010; Exley et al., 2011) . Striatal ␤2* nAChRs respond to ACh released from striatal cholinergic interneurons to gate the dynamic probability of DA release and govern its sensitivity to the frequency of activity in DA axons (Zhou et al., 2001; Rice and Cragg, 2004; Zhang and Sulzer, 2004) , which DA neurons change to signal information about reinforcers, or other salient stimuli and their cues (Schultz, 1998; Matsumoto and Hikosaka, 2009) . It has been shown that the striatal nAChRs that regulate DA release probability differ in sensorimotor-associated striatum [caudatoputamen (CPu)] versus limbic-associated striatum [nucleus accumbens (NAc)], in particular that ␣4(non-␣6) nAChRs are dominant in CPu but ␣4␣6* nAChRs are dominant in NAc (Exley et al., , 2011 . Since the nAChR subunit stoichiometries identified in striatum suggest that ␣6* and ␣5* nAChRs are mutually exclusive populations, these data suggest in turn that any function for ␣5 subunits in regulating DA release might also covary with striatal regions and be precluded in NAc. Here, by using mice with dele-tions for ␣4, ␣5, ␣6, or ␤3 subunits we defined the subunit compositions of the ␣4/␣6␤2* nAChRs that dynamically gate DA release probability in NAc core and in CPu.
Materials and Methods
Slice preparation and voltammetry. Coronal striatal slices (0.98 -1.18 mm anterior to bregma) (Franklin and Paxinos, 2008) , 300 m thick, were prepared using described methods (Exley et al., , 2011 ) from brains of adult male mice (C57BL/6J strain) of wild-type (Charles River), or ␣6 Ϫ/Ϫ , ␣4 Ϫ/Ϫ , ␣5 Ϫ/Ϫ or ␤3 Ϫ/Ϫ mice. Knock-out mice have been described previously (Marubio et al., 1999; Champtiaux et al., 2002; Cui et al., 2003; Salas et al., 2003) . They have normal gross phenotypes and were backcrossed with a wild-type C57BL/6J line for a minimum of 10 generations (as recommended by the Banbury Conference on Genetic Background in Mice, 1997) to ensure similar genetic backgrounds.
Extracellular dopamine concentration ([DA] o ) was monitored at 32°C using fast-scan cyclic voltammetry with 7-8 m carbon-fiber microelectrodes (tip length ϳ50 -100 m) and a Millar voltammeter (Julian Millar, Barts and London School of Medicine and Dentistry, London, UK) as described previously (Exley et al., , 2011 . In brief, the scanning voltage was a triangular waveform (Ϫ0.7 to ϩ1.3 V vs Ag/AgCl) at a scan rate of 800 V/s, with a frequency of 8 Hz. Evoked electrochemical currents were attributable to DA by potentials for peak oxidation and reduction currents seen for applied DA (ϩ500/600 and Ϫ250 mV respectively) (see Figs. 1b, 3b) . Electrodes were calibrated post hoc with 2 M DA in experimental media.
DA release was evoked by a local bipolar concentric electrode (25 m diameter, Pt/Ir; FHC). Stimulus pulses (200 s duration) were generated at the lowest current (0.5 mA) that generated maximal DA release with a single pulse. Release was Ca 2ϩ dependent and TTX sensitive (data not shown), and was not modulated by glutamate or GABA antagonists (Threlfell et al., 2010) .
Experimental design and analysis. Stimuli were repeated at 2.5 min intervals to ensure consistent release. Stimuli were either single pulses (1p) or trains of four pulses (4p) at frequencies ranging from "tonic" (1-10 Hz) to "phasic" burst frequencies (Ն15-40 Hz) of DA neurons that signal salient events in vivo (e.g., reward-predicting stimuli) (Schultz, 1986; Hyland et al., 2002; Bayer and Glimcher, 2005) . The highest frequency (100 Hz) is particularly useful for probing changes in DA release probability (Rice and Cragg, 2004; Threlfell et al., 2010) . CPu recording sites were located centrally in the dorsal quartile of CPu; those in NAc were ventral to the anterior commissure in the NAc core.
To assess the effects of frequency and drug, data were obtained from a population of sites where frequency and drug were varied at each site (see Figs. 1, 3) . To assess the effects of nicotine (see Figs. 2, 4), a simplified protocol of two types of stimuli was used (single pulse or a four-pulse, 100 Hz train), and data were obtained from multiple recording locations each sampled only once. Data are means Ϯ SEM, and the sample size, n, is the number of observations. The number of animals for each dataset is three or more. Effects of genotype, nAChR drugs, and/or region during stimuli of varying frequency were analyzed by three-way ANOVA and Holm-Sidak post hoc multiplecomparison t tests. The effects of each nAChR drug during stimuli of varying frequency in a given genotype were subsequently analyzed by two-way ANOVA and Bonferroni post hoc multiple-comparison t tests. Statistical analyses were performed using Sigmaplot11 and GraphPad Prism 4.
Drugs. ␣-conotoxin MII (␣-CtxMII) was synthesized as previously (Cartier et al., 1996) and used at concentrations which have no effects at non-␣6/␣3 nAChRs (Cartier et al., 1996) but maximally inhibit the ␣-CtxMIIsensitive component of striatal DA release (Exley et al., , 2011 . Deletion of ␣6 subunits eliminates ␣-CtxMII binding (Champtiaux et al., 2003) and, as expected, eliminated effects of ␣-CtxMII (30 -100 nM) on evoked DA release in ␣6 Ϫ/Ϫ mice (1p/4p stimuli, data not shown), and thus the effect of ␣-Ctx-MII was not explored further in ␣6 Ϫ/Ϫ mice. Nicotine (tartrate) and dihydro-␤-erythroidine (DH␤E) were from Tocris Bioscience, and other reagents were from Sigma-Aldrich.
Results
We probed the identities of the striatal ␤2* nAChRs through which endogenous ACh regulates DA transmission in NAc core and in CPu. We assessed the effect of the deletion of subunits ␣4, ␣5, ␣6, or ␤3 on the regulation of DA release evoked by brief trains of a broad spectrum of frequencies (5-100 Hz). We combined this approach with the application of the ␣6-selective antagonist ␣-CtxMII and then the broad-spectrum ␤2-antagonist DH␤E to explore the role of first ␣6* nAChRs and subsequently non-␣6 nAChRs (which in striatum are ␣4* nAChRs). By thus combining individual subunit deletions with the effects of pharmacological antagonists, we can deduce the nAChRs subunits that are responsible for ACh control of DA release.
In NAc core, in wild-type mice in control (drug-free) conditions, peak evoked extracellular DA concentration ([DA] o ) was only weakly sensitive to frequency (Fig. 1a) , following a bellshaped curve, as reported previously (Exley et al., , 2011 . These observations are consistent with high initial DA release probability and accompanying short-term depression (Rice and Cragg, 2004; Zhang and Sulzer, 2004) . In NAc core in wild-type mice as shown previously, ␣-CtxMII (30 nM) reduced [DA] o evoked by low frequencies (Յ10 Hz) but promoted frequency sensitivity, which increased [DA] o evoked by high frequency (100 Hz) (Exley et al., , 2011 . Subsequent application of the broad-spectrum nAChR antagonist DH␤E (1 M) did not further modify release (Fig. 1a) , consistent with the dominant role of ␣6␤2*-nAChRs in NAc shown previously (Exley et al., , 2011 . In mice with deletions of ␣6, ␤3, or ␣4 subunits, peak evoked [DA] o values in NAc core were modified compared with wild type (three-way ANOVAs, genotype ϫ frequency ϫ drug treatment, pairwise interactions, p Ͻ 0.001). Release showed greater frequency sensitivity even in drugfree conditions (two-way ANOVA, frequency ϫ genotype, p Ͻ 0.001). This was due to the significant loss of nAChR control of DA release: the effects of ␣-CtxMII and DH␤E were markedly attenuated, causing only slight additional changes to [DA] o (Fig. 1a) . In ␣5 nulls by contrast, the frequency sensitivity of DA release in drug-free conditions followed a bellshaped curve unlike the other null mice. ␣-CtxMII strongly increased frequency sensitivity with bidirectional effects on evoked [DA] o , as seen in wild-type mice (Fig. 1a) . These data suggest that the ␤2* nAChRs regulating DA release in NAc core depend strongly on ␣6, ␣4, and ␤3 subunits, but less so on ␣5 subunits, suggesting that the ␣4␣6␣␤2␤3 nAChR in NAc core is the dominant nAChR. The minor effects of nAChR antagonists seen in ␣6-, ␤3-, or ␣4-null mice suggest only minor roles for any ␣4(non-␣6), ␣6(non␤3), or ␣6(non-␣4) nAChRs.
We tested in NAc core whether the effects of nicotine on DA release showed similar subunit dependence, using a simplified protocol to compare the ratio of DA release by a single pulse versus 4p at 100 Hz, for which nAChR effects are most marked (Exley et al., , 2011 . Nicotine (500 nM) has been shown previously to desensitize ␤2* nAChRs with the same outcome as nAChR antagonism (Zhou et al., 2001; Rice and Cragg, 2004; Zhang and Sulzer, 2004) : consistent with these data, nicotine in wild types reduced 1p release, which promoted the sensitivity of [DA] o to activity (4p/100 Hz vs 1p) (Fig. 2) . However, in ␣6-, ␣4-, or ␤3-nulls, but not ␣5-nulls, the ratios of [DA] o evoked by 4p (100 Hz) versus 1p were elevated compared with wild-type mice in drug-free conditions (Fig. 2b , as seen in experiments for Fig. 1 ), and were not enhanced further by nicotine (500 nM). This ratio was enhanced by nicotine in ␣5-nulls (Fig. 2) .
We explored the nAChR subunits responsible for ACh control of DA release in CPu. In CPu wild types, as in NAc, [DA] o was only weakly sensitive to frequency (Fig. 3a) , following a bell-shaped curve, as reported previously . However, there were key differences to NAc core in effects of genotypes and nAChR drugs (three-way ANOVAs: region ϫ frequency ϫ genotype interactions, p Ͻ 0.001; region ϫ frequency ϫ drug treatment interactions in wild types, p Ͻ 0.01). In CPu, unlike in NAc, ␣4(non-␣6)␤2* nAChRs strongly govern DA release probability, and ␣6* nAChRs appear to have a minor role . As shown previously, in wild types, ␣-CtxMII (30 nM) had only small effect compared with DH␤E (1 M) on frequency sensitivity of release (Fig. 3a) . Surprisingly however, subunit deletion had no significant effects on the net nAChR regulation of frequency sensitivity of DA release (two-way ANOVA, frequency ϫ genotype, p Ͼ 0.05). In drug-free conditions across genotypes, frequency sensitivity remained limited and was significantly promoted by the broad-spectrum antagonist DH␤E (Fig. 3a) . However, the effects of ␣-CtxMII varied with genotype (pairwise post hoc t tests, p Ͻ 0.001), revealing roles for key individual subunits and substitution of subtypes that maintain net nAChR control after deletion. Deletion of ␣6 subunits eliminated ␣-CtxMII effects (data not shown) and indicated that non-␣6 nAChRs (i.e., ␣4* nAChRs) are entirely sufficient to support nAChR control of DA. Deletion of ␤3 subunits, however, eliminated the modest ␣-CtxMII effects (Fig. 3a) , indicating that the minor ␣6-dependent component seen in wild types results from ␣6␤3(␤2)* nAChRs. After deletion of either ␣4 or ␣5 subunits, the substantial remaining nAChR control was entirely ␣-CtxMII sensitive (Fig. 3a) . These data indicate first that while ␣6 nAChRs do not normally play a major role, the ␣6␤3(␤2) nAChRs can be functional in CPu under appropriate conditions, substituting for the normally dominant ␣4(non-␣6)␤2* nAChRs. Second, they indicate that normally dominant ␣4␤2* control depends critically on the availability of ␣5 subunits, presumably through the ␣4␣5␤2 nAChRs, which are known to be present (Gotti et al., 2010) . Subunit knockout in CPu had similar impact on the net effects of nicotine. In all knockouts, the ratios of [DA] o evoked by 4p (100 Hz) versus 1p were not different compared with wild types in drug-free conditions, and were significantly enhanced by nicotine (500 nM) (Fig. 4) .
Discussion
We show that control of DA transmission by ACh and nicotine in striatum is dominated by mutually exclusive populations of nAChRs: ␣4␣6␤2␤3 nAChRs in NAc core and ␣4␣5␤2 nAChRs in dorsal CPu. We show also a difference in the necessity versus sufficiency for ␣4, ␣5, ␣6, or ␤3 subunits in the nAChR regulation of DA release in CPu versus NAc core.
These data corroborate findings that ␣4␣6␤2* nAChRs are necessary for ACh and nicotine to regulate DA release probability in NAc (Exley et al., 2011) , and reveal further that this control codepends on ␤3 subunits, through presumably ␣4␣6␤2␤3 nAChRs. We find evidence for only minor roles for other subtypes after subunit deletions [i.e., the ␣4/␣5(non-␣6), ␣6(non␤3), or ␣6(non-␣4) nAChRs], but, given the ␣-CtxMII sensitivity of release under normal conditions, only the ␣6* nAChRs of these could be expected to contribute, if any. A role for ␣4␣6␤2␤3 nAChRs in NAc core is supported by the presence of this receptor within striatum (Gotti et al., 2010) and by reductions in ␣-CtxMII-sensitive striatal DA release and nAChR binding after ␣4 or ␤3 subunit deletion (Champtiaux et al., 2002; Salminen et al., 2005 Salminen et al., , 2007 . The dominance of this nAChR type is, however. slightly surprising given that it has been suggested to account for only 14% of nAChRs here (Gotti et al., 2010) . This disparity emphasizes that it is difficult to infer the function of nAChR subtypes in regulating DA transmission from nAChR expression levels alone . It could be argued that the protocol used here, which drives DA release in slices during discrete, subsecond but synchronous activation of DA and ACh release, better demonstrates the function of particular nAChR subtypes over others. However, the same protocol in the adjacent striatal region, CPu, reveals a different subunit dependence.
In dorsal CPu, we show that, in contrast to NAc core, no single type of subunit (of ␣4-␣6, ␤3) is necessary to support nAChR regulation of DA release by ACh/nicotine. Rather, alternative nAChR subtypes become sufficient. We show in particular after deletion of individual subunits, that either ␣4(non-␣6) or ␣6(non-␣4) nAChRs can operate and be sufficient, that ␣6 function requires ␤3, and that ␣4 function critically requires ␣5. Together, these data indicate that the nAChR subtypes that govern DA release probability in CPu are substitutable, unlike in NAc core, and that while ␣6(non-␣4)␤2␤3-nAChRs can regulate DA release, DA in CPu is normally dominantly regulated by ␣4(non-␣6)␤2-nAChRs, which require an ␣5 subunit (i.e., ␣4␣5␤2 nAChRs).
Variation between CPu and NAc core in substitutability of alternative nAChR subtypes after individual subunit deletion, is likely to occur at the level of nAChR formation and/or functional coupling rather than through compensatory upregulation in expression levels of alternate subunits, because there are no reported changes in transcript levels of alternate subunits after deletion of individual subunits (Champtiaux et al., 2002 (Champtiaux et al., , 2003 Cui et al., 2003; Salas et al., 2003; Grady et al., 2007) . Variation in such mechanisms between CPu and NAc is not altogether surprising given that these axons derive from different parent DA neurons, in substantia nigra pars compacta (SNc) versus ventral tegmental area (VTA), respectively. However, the mechanisms that could differentiate receptor trafficking and functional coupling in CPu versus NAc have yet to be identified. We have, however, previously shown that after deletion of either ␣4 or ␣6 subunits, the lack of "rescue" of net nAChR control of DA release by other subunits in NAc is not due to ACh levels being below some threshold that is required for nAChR activation: inhibitors of ACh-esterase, which promote ACh levels, do not restore any nAChR control by remaining subunits (Exley et al., 2011) .
In striatum, the ␣5 subunit has been shown to form a receptor with ␣4 and ␤2 subunits of similar properties to the "high sensitivity" ␣4␤2 nAChR (Grady et al., 2010) . It would not have been predicted, however, that the ␣5␣4␤2 nAChR accounts for the entire population of the ␣-CtxMII-resistant regulation of DA release in CPu, as shown here: coimmunoprecipitation studies suggest that ϳ40% of non-␣6 (i.e., ␣4) nAChRs do not contain ␣5 (Gotti et al., 2010) .
In conclusion, we have identified that discrete nAChR populations govern the regulation of DA release probability in NAc core versus CPu. We reveal that ␣5 subunits are essential to ␣4* nAChR function in CPu but not in NAc core, regions respectively associated with instrumental and habitual behaviors versus pavlovian associa- tions. The function of ␣5* nAChRs in regulating activity in DA neurons within VTA or SNc is not yet resolved, but the functions of nAChRs we show at axon terminals suggest that modifications to ␣5 function might modify the risk of nicotine dependence through a dysregulation of behaviors encoded at the level of dorsal striatum.
